Striving to transform the treatment of disease by harnessing the power of cell therapy

Our mission is to discover and develop cell therapies that can change the way we treat disease and improve the lives of patients. 

Our team is committed to realizing the potential of regenerative medicine to help patients suffering from disease by developing new and impactful cellular therapies.

BlueRock is a wholly-owned, independently operated subsidiary of Bayer AG as a cornerstone of its Cell & Gene Therapy Platform.